2 completed, 1 active not recruiting. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Micron Biomedical, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV), 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV), Placebo - Rotavirus Infections | Phase 1 | Active not recruiting | Centers for Disease Control and Prevention | 50 | 2025-07-07 | 2026-03-05 |
| Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial Measles Rubella Vaccine (MRV-SC), MRV-MNP, PLA-MNP - Measles, Rubella | Phase 1 / Phase 2 | Completed | Micron Biomedical, Inc | 281 | 2021-05-19 | 2023-03-29 |
| Microneedle Patch Study in Healthy Infants/Young Children Microneedle Formulation 1, Microneedle Formulation 2 - Vaccination, Skin Absorption | Not applicable | Completed | Emory University | 33 | 2017-07-11 | 2020-11-10 |
Infections (1) · Measles (1) · Rotavirus Infections (1) · Rubella (1)
United States (2) · The Gambia (1)
Christina Rostad, MD (1) · Ed Clarke, MD (1) · Evan Anderson, MD (1) · Lauren Nolan, PA-C (1)